RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INSM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Insmed stock downgraded after the last trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Insmed stock price fell by -0.695% on the last day (Thursday, 28th Mar 2024) from $27.32 to $27.13. During the last trading day the stock fluctuated 2.02% from a day low at $27.01 to a day high of $27.55. The price has risen in 6 of the last 10 days and is up by 3.12% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -110 thousand shares and in total, 1 million shares were bought and sold for approximately $29.07 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.06% during the next 3 months and, with a 90% probability hold a price between $23.30 and $26.08 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INSM Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, March 15, 2024, and so far it has risen 5.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Insmed stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $27.56. On a fall, the stock will find some support from the short-term average at $26.83. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Insmed stock

Insmed finds support from accumulated volume at $26.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.545 between high and low, or 2.02%. For the last week, the stock has had daily average volatility of 2.35%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INSM) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Insmed to open at $27.23, and during the day (based on 14 day Average True Range), to move between $26.24 and $28.02, which gives a possible trading interval of +/-$0.89 (+/-3.29%) up or down from last closing price. If Insmed takes out the full calculated possible swing range there will be an estimated 6.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $27.15 (0.07%) than the support at $26.60 (1.95%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Insmed stock A Buy?

Insmed holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.649 Sell Candidate Downgraded

Predicted Opening Price for Insmed of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$27.23 ( 0.362%) $27.13

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INSM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 27.77 2.37 %
R2 27.57 1.60 %
R1 27.44 1.13 %
Current price: 27.13
Support S1 27.02 -0.405 %
S2 26.89 -0.88 %
S3 26.68 -1.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 28.75 5.97 %
R2 27.80 2.47 %
R1 27.15 0.0737 %
Current price 27.13
Support S1 26.60 -1.95%
S2 26.14 -3.65%
S3 25.72 -5.20%

FAQ

What is the symbol for Insmed Stock and on which exchange is it traded?
The symbol for Insmed is INSM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Insmed Stock?
Insmed holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Insmed Stock?
Insmed Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Insmed Stock.

What's the current price of Insmed Stock?
As of the end of day on the 2024-03-28, the price of an Insmed (INSM) share was $27.13.

What is the 52-week high and low for Insmed Stock?
The 52-week high for Insmed Stock is $32.00 and the 52-week low is $16.26.

What is the market capitalization of Insmed Stock?
As of the 2024-03-28, the market capitalization of Insmed is 4.029B.

When is the next earnings date for Insmed?
The upcoming earnings date for Insmed is May 02, 2024.
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT